Latest Pharmacy News
2018 to 2024 Saw Rise in Insurance Denials for Brand-Name Drugs
posted July 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
2017 to 2022 Saw More Than Doubling in Use of GLP-1 Receptor Agonists
posted July 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
GLP-1 Receptor Agonist Use Does Not Increase Insulin Discontinuation With Type 2 Diabetes
posted July 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
GLP-1 Receptor Agonist Use Linked to Higher Risk for Ischemic Optic Neuropathy
posted July 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Weight-Loss Surgery Produces Lasting Diabetes Remission .jpg)
Pregnancy Complications Linked to Subsequent Risk for Cardiometabolic-Renal Conditions 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors Related Articles
Nonpharmacologic Therapy Cuts Opioid Use Disorder Risk With Low Back Pain 
Study Looks at Approaches to Prescribing Obesity Medications for Older Adults 
Bariatric Surgery Is Effective Rescue Strategy After GLP-1 Receptor Agonist Failure 
Study IDs Real-World Reasons for Lemborexant Discontinuation Pharmacy Conference Highlights
Pharmacy Monthly Briefings
Pharmacy Conference News
Stay Connected
